Published in Science on April 02, 1937
Toxoplasmic encephalomyelitis: III. A new case of granulomatous encephalomyelitis due to a protozoon. Am J Pathol (1939) 7.25
Sarcosporidiosis or Toxoplasmosis in Man and Guinea-Pig. Am J Pathol (1945) 2.68
Toxoplasmosis, a summary of the disease with report of a case. Br J Ophthalmol (1949) 2.04
THE PATHOGENIC RICKETTSIAE WITH PARTICULAR REFERENCE TO THEIR NATURE, BIOLOGIC PROPERTIES, AND CLASSIFICATION. Bacteriol Rev (1942) 1.76
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : IV. VARIATIONS IN NEUROINVASIVENESS IN DIFIERENT SPECIES. J Exp Med (1938) 1.20
Sexual recombination punctuated by outbreaks and clonal expansions predicts Toxoplasma gondii population genetics. Int J Parasitol (2009) 1.17
Attachment of Toxoplasma gondii to host cells is host cell cycle dependent. Infect Immun (1996) 1.14
Toxoplasma infection at different ages, studied by the skin-test method. J Hyg (Lond) (1953) 0.82
TOXOPLASMIC ENCEPHALOMYELITIS : IV. EXPERIMENTAL TRANSMISSION OF THE INFECTION TO ANIMALS FROM A HUMAN INFANT. J Exp Med (1940) 0.81
The early years of Toxoplasma research: What's past is prologue. Int J Parasitol (2009) 0.81
Toxoplasmic choroidoretinitis in the adult. Br J Ophthalmol (1954) 0.80
[Histology of toxoplasmosis of skin; with reference to the whole literature on toxoplasmosis]. Arch Dermatol Syph (1952) 0.80
Pseudoglioma: A Clinico-Pathologic Study of Fifteen Cases. Trans Am Ophthalmol Soc (1950) 0.78
Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls. Microbes Infect (2015) 0.75
Elevated concentrations of matrix metalloproteinase-12 and elastin degradation products in the sera of pregnant women infected with Toxoplasma gondii. Ann Trop Med Parasitol (2011) 0.75
Attachment of Toxoplasma gondii to a specific membrane fraction of CHO cells. Infect Immun (2000) 0.75
Toxoplasmosis (Report of Eye Findings in Infant Twins). Trans Am Ophthalmol Soc (1944) 0.75
Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science (1948) 19.46
IDENTIFICATION OF THE FILTRABLE, TRANSMISSIBLE NEUROLYTIC AGENT ISOLATED FROM TOXOPLASMA-INFECTED TISSUE AS A NEW PLEUROPNEUMONIA-LIKE MICROBE. Science (1938) 11.12
TEMPORARY PREVENTION BY CHEMICAL MEANS OF INTRANASAL INFECTION OF MICE WITH EQUINE ENCEPHALOMYELITIS VIRUS. Science (1934) 8.21
STUDIES ON THE ETIOLOGY OF SNUFFLES IN STOCK RABBITS : PARANASAL SINUSITIS A FACTOR IN THE INTERPRETATION OF EXPERIMENTAL RESULTS. J Exp Med (1923) 5.94
ISOLATION OF A FILTRABLE, TRANSMISSIBLE AGENT WITH "NEUROLYTI" PROPERTIES FROM TOXOPLASMA-INFECTED TISSUES. Science (1938) 5.54
AN ACQUIRED RESISTANCE OF GROWING ANIMALS TO CERTAIN NEUROTROPIC VIRUSES IN THE ABSENCE OF HUMORAL ANTIBODIES OR PREVIOUS EXPOSURE TO INFECTION. J Exp Med (1936) 5.38
MICE AS CARRIERS OF PATHOGENIC PLEUROPNEUMONIA-LIKE MICROORGANISMS. Science (1939) 4.76
EXPERIMENTAL PROLIFERATIVE ARTHRITIS IN MICE PRODUCED BY FILTRABLE, PLEUROPNEUMONIA-LIKE MICROORGANISMS. Science (1939) 4.64
TRANSMISSION TO RODENTS OF LANSING TYPE POLIOMYELITIS VIRUS ORIGINATING IN THE MIDDLE EAST. Science (1943) 4.57
DIFFERENCES BETWEEN MITOCHONDRIA AND BACTERIA. J Exp Med (1922) 4.55
RELATIONSHIP OF THE VIRUSES OF VESICULAR STOMATITIS AND OF EQUINE ENCEPHALOMYELITIS. Science (1933) 4.28
PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science (1945) 4.05
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : III. EFFECT OF AGE AND PATHWAY OF INFECTION ON THE CHARACTER AND LOCALIZATION OF LESIONS IN THE CENTRAL NERVOUS SYSTEM. J Exp Med (1938) 4.04
BACTERIOLOGICAL STUDIES ON AN EPIZOOTIC OF INTESTINAL DISEASE IN SUCKLING AND NEWLY WEANED MICE. J Exp Med (1934) 3.85
THE THERAPEUTIC EFFECTIVENESS OF A PRACTICALLY NONTOXIC NEW COMPOUND (CALCIUM AUROTHIOMALATE) IN EXPERIMENTAL, PROLIFERATIVE, CHRONIC ARTHRITIS OF MICE. Science (1940) 3.63
INSECTS AND EPIDEMIOLOGY OF POLIOMYELITIS. Science (1942) 3.59
Intranuclear Inclusion Bodies in the Tissue Reactions Produced by Injections of Certain Foreign Substances. Am J Pathol (1937) 3.58
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : I. EFFECT OF AGE ON THE INVASION OF THE BRAIN BY VIRUS INSTILLED IN THE NOSE. J Exp Med (1937) 3.54
Visceral lesions in infectious polyneuritis: (Infectious neuronitis, acute polyneuritis with facial diplegia, guillain-barré syndrome, landry's paralysis). Am J Pathol (1941) 3.52
FLIES AS CARRIERS OF POLIOMYELITIS VIRUS IN URBAN EPIDEMICS. Science (1941) 3.48
EFFECT OF LOCAL EDEMA AND INFLAMMATION IN THE SKIN OF THE MOUSE ON THE PROGRESSION OF HERPES VIRUS. Science (1941) 2.66
Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis (1985) 2.64
ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : II. IMMUNIZATION WITH FORMOLIZED VIRUS. J Exp Med (1936) 2.45
BACTERIUM GRANULOSIS AND TRACHOMA OF AN URBAN WHITE POPULATION. Science (1930) 2.33
EXPERIMENTS ON THE CULTIVATION OF THE ACTIVE AGENT OF MOSAIC DISEASE OF TOBACCO AND TOMATO. Science (1924) 2.29
HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS. J Exp Med (1936) 2.25
PREVENTION OF EXPERIMENTAL EQUINE ENCEPHALOMYELITIS IN GUINEA PIGS BY MEANS OF VIRUS ADSORBED ON ALUMINUM HYDROXIDE. Science (1934) 2.24
FACTORS INFLUENCING ANAEROBIOSIS, WITH SPECIAL REFERENCE TO THE USE OF FRESH TISSUE. J Exp Med (1921) 2.24
Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells. Proc Natl Acad Sci U S A (1970) 2.04
THE ROLE OF STREPTOCOCCI IN EXPERIMENTAL POLIOMYELITIS OF THE MONKEY. J Exp Med (1928) 1.67
ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : III. QUANTITATIVE STUDIES OF SERUM ANTIVIRAL BODIES IN ANIMALS IMMUNIZED WITH ACTIVE AND INACTIVE VIRUS. J Exp Med (1936) 1.66
Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis (1981) 1.62
INFECTION IN MICE FOLLOWING INSTILLATION OF VESICULAR STOMATITIS VIRUS. Science (1933) 1.55
Amantadine hydrochloride. Analysis of data related to its proposed use for prevention of A2 influenza virus disease in human beings. JAMA (1967) 1.52
POLIOMYELITIS IN A LABORATORY WORKER EXPOSED TO THE VIRUS. Science (1941) 1.48
DIRECT TRANSMISSION OF HUMAN TRACHOMA TO THE MONKEY. Science (1930) 1.45
INVESTIGATIONS ON THE BACTERIOLOGY OF EPIDEMIC INFLUENZA. Science (1923) 1.43
Mortality from pneumonia and risk conditions during influenza epidemics. High influenza morbidity during nonepidemic years. JAMA (1977) 1.40
FATE OF NASALLY INSTILLED POLIOMYELITIS VIRUS IN NORMAL AND CONVALESCENT MONKEYS WITH SPECIAL REFERENCE TO THE PROBLEM OF HOST TO HOST TRANSMISSION. J Exp Med (1938) 1.36
ISOLATION BY CATAPHORESIS OF VIRUS FROM VACCINIA-RECOVERED RABBITS. Science (1929) 1.35
NUTRITION AS A FACTOR IN THE DEVELOPMENT OF CONSTITUTIONAL BARRIERS TO INVOLVEMENT OF THE NERVOUS SYSTEM BY CERTAIN VIRUSES. Science (1940) 1.28
DIFFERENTIAL FILTRATION AS A MEANS OF ISOLATING BACTERIUM GRANULOSIS. Science (1931) 1.25
Behaviour of Chimpanzee-avirulent Poliomyelitis Viruses in Experimentally Infected Human Volunteers. Br Med J (1955) 1.23
Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis. JAMA (1965) 1.20
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : IV. VARIATIONS IN NEUROINVASIVENESS IN DIFIERENT SPECIES. J Exp Med (1938) 1.20
Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses. Eur J Epidemiol (1991) 1.15
Amantadine and influenza: evaluation of conflicting reports. J Infect Dis (1978) 1.15
Herpes simplex and herpes genitalis viruses in etiology of some human cancers. Proc Natl Acad Sci U S A (1973) 1.14
Vaccination against poliomyelitis in economically underdeveloped countries. Bull World Health Organ (1980) 1.12
Inactivation of Certain Neurotropic Viruses in Vitro by Serum Lipids. Science (1947) 1.10
Perspectives on current use of some virus vaccines in the USA. Measles, rubella, poliomyelitis, and influenza in the USA: contrasts in control by vaccination. Pediatr Res (1979) 1.09
Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc Natl Acad Sci U S A (1992) 1.04
DISSOCIATION OF NEUTRAL VACCINE VIRUS-IMMUNE SERUM MIXTURES. Science (1929) 1.03
Reproductive capacity and viability at higher temperatures of various transformed hamster cell lines. J Natl Cancer Inst (1969) 0.99
Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine. Rev Infect Dis (1984) 0.98
Protection of Mice Against an Encephalitis Virus by Means of Organic-Solvent Extracts of Brain Tissue. Science (1948) 0.98
ACTIVE IMMUNIZATION OF GUINEA PIGS WITH THE VIRUS OF EQUINE ENCEPHALOMYELITIS : IV. EFFECT OF IMMUNE SERUM ON ANTIGENICITY OF ACTIVE AND INACTIVE VIRUS. J Exp Med (1936) 0.95
Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control. Eur J Epidemiol (1991) 0.95
Poliomyelitis vaccination. Evaluation and direction in continuing application. Am J Clin Pathol (1978) 0.94
Increase in preexisting cellular antigen-combining groups at different times after infection with different viruses. Proc Natl Acad Sci U S A (1970) 0.93
Immunization against measles by aerosol. Rev Infect Dis (1983) 0.92
The Presence of Poliomyelitis Virus in Human Cases and Carriers During the Winter. Yale J Biol Med (1944) 0.91
SIMPLIFIED PRODUCTION OF ANTIMENINGOCOCCIC SERUM. J Exp Med (1920) 0.91
Nonvirion antigens produced by herpes simplex viruses 1 and 2. Proc Natl Acad Sci U S A (1973) 0.90
ADDITIONAL PROPERTIES OF THE MEF1 STRAIN OF POLIOMYELITIS VIRUS, ESPECIALLY WITH REFERENCE TO ATTEMPTS AT CULTIVATION IN THE CHICK EMBRYO. J Bacteriol (1949) 0.90
Vaccine-associated poliomyelitis cases. Bull World Health Organ (1969) 0.90
SEPARATION OF THE TOXINS OF BACILLUS DYSENTERIAE SHIGA. J Exp Med (1923) 0.89
MULTIPLICATION AND SPREAD OF THE VIRUS OF ST. LOUIS ENCEPHALITIS IN MICE WITH SPECIAL EMPHASIS ON ITS FATE IN THE ALIMENTARY TRACT. J Exp Med (1947) 0.88
Nature and source of mycoplasma in various tissue cultures. Ann N Y Acad Sci (1967) 0.88
High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month-old and older infants. J Infect Dis (1985) 0.87
Strategy for rapid elimination and continuing control of poliomyelitis and other vaccine preventable diseases of children in developing countries. Br Med J (Clin Res Ed) (1986) 0.86
CONSTITUTIONAL BARRIERS TO INVOLVEMENT OF THE NERVOUS SYSTEM BY CERTAIN VIRUSES. Science (1940) 0.86
Varicella-zoster virus vaccine. JAMA (1977) 0.84
Inadequate serological surveys for immunity to poliomyelitis. Inadequate indicators of immune status of communities using oral poliovirus vaccine and inadequate guides to vaccination policy. Med J Aust (1983) 0.84
Different effects of chloramphenicol, dactinomycin, and streptovitacin A on synthesis of tumor and virion antigens in SV40 virus-infected cells. Proc Natl Acad Sci U S A (1966) 0.84
Overview and horizons in prevention of some human infectious diseases by vaccination. Am J Clin Pathol (1978) 0.83
PROTECTIVE ACTION OF CERTAIN CHEMICALS AGAINST INFECTION OF MONKEYS WITH NASALLY INSTILLED POLIOMYELITIS VIRUS. J Exp Med (1936) 0.81
Effectiveness of AIDS vaccines. Science (1991) 0.81
Genetic phenomena in experimental viral carcinogenesis. Search for such phenomena in cancers of children. Am J Dis Child (1966) 0.80
Concepts of the Immunology of Certain Virus Infections. Bull N Y Acad Med (1945) 0.80
Collaboration for accelerating progress in medical research. Science (1967) 0.80
Clinical trials of inhaled aerosol of human diploid and chick embryo measles vaccine. Lancet (1982) 0.80
Residual paralytic poliomyelitis in a tropical region of Brazil, 1969-1977: prevalence surveys in different age groups as indicators of changing incidence. Am J Epidemiol (1983) 0.80
Vaccine control of poliomyelitis in the 1980s. Yale J Biol Med (1983) 0.78
Suppression of malignancy in human cancer cells: issues and challenges. Proc Natl Acad Sci U S A (1981) 0.78
My last will and testament on rapid elimination and ultimate global eradication of poliomyelitis and measles. Pediatrics (1992) 0.77
Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. 1960. Bull World Health Organ (1999) 0.76
HIV vaccination dilemma. Nature (1993) 0.76
Editorial: Misery of recurrent herpes: what to do? N Engl J Med (1975) 0.76
Immunization: Evaluation of some currently available and prospective vaccines. JAMA (1981) 0.76
Are the herpes simplex-genitalis viruses a cause of certain human cancers? Adv Pathobiol (1976) 0.76
Viral hepatitis: problems of incidence and control in military personnel. Yale J Biol Med (1976) 0.75